XT
LENZ

XTX Topco’s LENZ Therapeutics LENZ Stock Holding History

XTX Topco’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.02M Buy
221,037
+135,255
+158% +$1.9M 0.04% 829
2025
Q4 		$1.37M Buy
+85,782
New +$2.5M 0.04% 798
2024
Q1 		– Sell
-2,782
Closed -$51K – 2411
2023
Q4 		$51K Buy
2,782
+725
+35% +$12K 0.01% 1228
2023
Q3 		$35.7K Buy
+2,057
New +$35.8K 0.01% 1316
2022
Q3 		– Sell
-1,510
Closed -$29K – 1434
2022
Q2 		$29K Buy
+1,510
New +$33.7K 0.01% 794

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

XTX Topco's LENZ Position: Q1 2026 in Review

XTX Topco increased its LENZ Therapeutics (LENZ) stake by 158% in Q1 2026, buying an estimated $1.9M and bringing the position to 221,037 shares worth $2.02M. The position accounts for 0.04% of the portfolio, ranked #829.

XTX Topco first reported a position in LENZ in Q2 2022 and has held it in 5 quarters since. 145 funds tracked by Wall St. Rank hold LENZ as of Q1 2026.

  • XTX Topco held 221,037 shares of LENZ Therapeutics worth $2.02M as of Q1 2026.
  • XTX Topco bought 135,255 LENZ Therapeutics shares in Q1 2026, an estimated $1.9M.
  • LENZ Therapeutics made up 0.04% of XTX Topco's portfolio in Q1 2026, its #829 holding.
  • XTX Topco first reported a position in LENZ Therapeutics in Q2 2022 and has held it in 5 quarters since.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.